Ronald Ghossein

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

116h-index78.8kcitations902works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(258), Nutrition, Genetics, and Disease(76), Salivary Gland Tumors Diagnosis and Treatment(65), Ovarian cancer diagnosis and treatment(63), Virus-based gene therapy research(61)

Publications824 total

Supplementary Table 6 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table and Figure Legends from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Figure 4 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table 4 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table 2 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table 7 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table 5 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Figure 1 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table 1 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Table S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S6 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S5 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
The prognostic impact of blood vessel invasion in infiltrative papillary thyroid carcinoma: a retrospective case–control study
Histopathology·2025
page 1 of 42Next →

Frequent Co-authors

James A. Fagin(18), R. Michael Tuttle(14), Jatin P. Shah(14), Ashok R. Shaha(14), Ian Ganly(13), Jeffrey A. Knauf(9), Snehal G. Patel(8), Diane L. Carlson(7), Timothy A. Chan(6), Iñigo Landa(6), Steven M. Larson(6), Luc G.T. Morris(6), Bhuvanesh Singh(6), Nora Katabi(6), Julio C. Ricarte‐Filho(5), Eric J. Sherman(5), Richard J. Wong(5), Tihana Ibrahimpašić(4), Bin Xu(4), Alan L. Ho(4)